PMA supplement
P800022 S050: COSMODERM 1 HUMAN-BASED COLLAGEN, COSMODERM 2 HUMAN-BASED COLLAGEN AND COSMOPLAST HUMAN-BASED COLLAGEN
FDA PMA supplement · Panel Track · Allergan
Key facts
| Original PMA | P800022 |
|---|---|
| Supplement number | S050 |
| Supplement type | Panel Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | COSMODERM 1 HUMAN-BASED COLLAGEN, COSMODERM 2 HUMAN-BASED COLLAGEN AND COSMOPLAST HUMAN-BASED COLLAGEN |
| Generic name | Implant, dermal, for aesthetic use |
| Applicant | Allergan |
| Product code | LMH |
| Received date | May 16, 2001 |
| Decision date | Mar 11, 2003 |
| Docket number | 03M-0114 |
| Notice date | Mar 28, 2003 |
At a glance
- No Expedited review granted
- Yes Approval order on file
- Yes Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: